HISTONE DEACETYLASE INHIBITOR INDUCED ANTI-MYELOMA ACTIVITY IS MEDIATED PRINCIPALLY VIA CLASS I DEACETYLASE INHIBITION

被引：0
|
作者：
Mithraprabhu, S. [1 ]
Kalff, A. [2 ]
Quach, H. [3 ]
Khong, T. [4 ]
Andrew, A. [5 ,6 ]
机构：
[1] Monash Univ, Alfred Hlth, Melbourne, Vic, Australia
[2] Alfred Hosp, Malignant Hematol & Stem Cell Transplantat, Melbourne, Vic, Australia
[3] Monash Univ, Dept Clin Hematol, Clayton, Vic, Australia
[4] Monash Univ, Alfred Hosp, Australian Ctr Blood Dis, Melbourne, Vic, Australia
[5] Monash Univ, Alfred Hosp, ACBD, MH&SCT, Melbourne, Vic, Australia
[6] Monash Univ, Alfred Hosp, DCH, Melbourne, Vic, Australia
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0260
引用
收藏
页码：104 / 105
页数：2
相关论文
共 50 条
  • [41] Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1α activity
    Lee, YM
    Kim, SH
    Kim, HS
    Son, MJ
    Nakajima, H
    Kwon, HJ
    Kim, KW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 300 (01) : 241 - 246
  • [42] Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy
    Shen, Li
    Pili, Roberto
    ONCOIMMUNOLOGY, 2012, 1 (06): : 948 - 950
  • [43] Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
    Lobera, Mercedes
    Madauss, Kevin P.
    Pohlhaus, Denise T.
    Wright, Quentin G.
    Trocha, Mark
    Schmidt, Darby R.
    Baloglu, Erkan
    Trump, Ryan P.
    Head, Martha S.
    Hofmann, Glenn A.
    Murray-Thompson, Monique
    Schwartz, Benjamin
    Chakravorty, Subhas
    Wu, Zining
    Mander, Palwinder K.
    Kruidenier, Laurens
    Reid, Robert A.
    Burkhart, William
    Turunen, Brandon J.
    Rong, James X.
    Wagner, Craig
    Moyer, Mary B.
    Wells, Carrow
    Hong, Xuan
    Moore, John T.
    Williams, Jon D.
    Soler, Dulce
    Ghosh, Shomir
    Nolan, Michael A.
    NATURE CHEMICAL BIOLOGY, 2013, 9 (05) : 319 - +
  • [44] Dissection of Anti-tumor Activity of Histone Deacetylase Inhibitor SAHA in Nasopharyngeal Carcinoma Cells via Quantitative Phosphoproteomics
    Huang, Huichao
    Fu, Ying
    Zhang, Ye
    Peng, Fang
    Lu, Miaolong
    Feng, Yilu
    Chen, Lin
    Chen, Zhuchu
    Li, Maoyu
    Chen, Yongheng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [45] Class I histone deacetylase inhibition by aryl butenoic acid derivatives: In silico and in vitro studies
    Bora, Gamze
    Sari, Suat
    Taskor, Gulce
    Dalkara, Sevim
    Erdem-Yurter, Hayat
    JOURNAL OF RESEARCH IN PHARMACY, 2019, 23 (05): : 952 - 959
  • [46] Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
    Lobera M.
    Madauss K.P.
    Pohlhaus D.T.
    Wright Q.G.
    Trocha M.
    Schmidt D.R.
    Baloglu E.
    Trump R.P.
    Head M.S.
    Hofmann G.A.
    Murray-Thompson M.
    Schwartz B.
    Chakravorty S.
    Wu Z.
    Mander P.K.
    Kruidenier L.
    Reid R.A.
    Burkhart W.
    Turunen B.J.
    Rong J.X.
    Wagner C.
    Moyer M.B.
    Wells C.
    Hong X.
    Moore J.T.
    Williams J.D.
    Soler D.
    Ghosh S.
    Nolan M.A.
    Nature Chemical Biology, 2013, 9 (5) : 319 - 325
  • [47] Selective Class I Histone Deacetylase Inhibition Suppresses Hypoxia-Induced Cardiopulmonary Remodeling Through an Antiproliferative Mechanism
    Cavasin, Maria A.
    Demos-Davies, Kim
    Horn, Todd R.
    Walker, Lori A.
    Lemon, Douglas D.
    Birdsey, Nicholas
    Weiser-Evans, Mary C. M.
    Harral, Julie
    Irwin, David C.
    Anwar, Adil
    Yeager, Michael E.
    Li, Min
    Watson, Peter A.
    Nemenoff, Raphael A.
    Buttrick, Peter M.
    Stenmark, Kurt R.
    McKinsey, Timothy A.
    CIRCULATION RESEARCH, 2012, 110 (05) : 739 - U250
  • [48] Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824
    Mei, Qinglang
    Xu, Xiaohan
    Gao, Danling
    Xu, Yuting
    Yang, Jinbo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [49] The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
    Marks, PA
    CELL CYCLE, 2004, 3 (05) : 534 - 535
  • [50] Restoration of Bone Balance Via Activin a Inhibition Results in Anti-Myeloma Activity
    Vallet, Sonia
    Mukherjee, Siddhartha
    Vaghela, Nileshwari
    Pozzi, Samantha
    Santo, Loredana
    Cirstea, Diana
    Fulciniti, Mariateresa
    Rahemtullah, Aliyah
    Attar, Eyal
    Guimaraes, Alexander R.
    Xie, Wanling
    Patel, Chirayu
    Schoonmaker, Jesse
    Weller, Edie
    Hideshima, Teru
    Munshi, Nilchil C.
    Seehra, Jas
    Scadden, David T.
    Anderson, Kenneth C.
    Raje, Noopur
    BLOOD, 2008, 112 (11) : 240 - 240
12345